Seasoned investor and operating executive focused on value-oriented private equity and growth investments across technology, industrials and healthcare. Thomas Dobbins combines prior investment banking and corporate operating experience to lead carve-outs, operational turnarounds and board-level strategy. Active in deal sourcing, portfolio transformation and capital structure optimization, he is known for hands-on governance and exit-driven value creation. Frequent collaborator with PE sponsors, management teams and institutional investors.
Seasoned investor and operating executive focused on value-oriented private equity and growth investments across technology, industrials and healthcare. Thomas Dobbins combines prior investment banking and corporate operating experience to lead carve-outs, operational turnarounds and board-level strategy. Active in deal sourcing, portfolio transformation and capital structure optimization, he is known for hands-on governance and exit-driven value creation. Frequent collaborator with PE sponsors, management teams and institutional investors.
Value-driven private equity investor and operator specializing in technology, industrials and healthcare. Emphasizes carve-outs, operational turnarounds and capital structure optimization to convert underperforming assets into exit-ready businesses. Combines investment-banking rigor with hands-on governance, active board engagement and close collaboration with sponsors and management. Underwriting prioritizes cash-flow improvement, margin expansion and realistic exit pathways over multiple-year horizons, with disciplined leverage and tactical bolt-on growth.
Value-driven private equity investor and operator specializing in technology, industrials and healthcare. Emphasizes carve-outs, operational turnarounds and capital structure optimization to convert underperforming assets into exit-ready businesses. Combines investment-banking rigor with hands-on governance, active board engagement and close collaboration with sponsors and management. Underwriting prioritizes cash-flow improvement, margin expansion and realistic exit pathways over multiple-year horizons, with disciplined leverage and tactical bolt-on growth.
| Trades 3051 | Longs Won 2232/3051 73% | Profit Factor 9.19 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $385,538.36 |
| Average Win $66,801.69 | Best Trade (Dec 31) $14.23M | Sharpe Ratio -10.59 |
| Average Loss -$19,818.04 | Worst Trade (Sep 01) -$706,879.61 | Z-Score 16.75 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 5d | Expectancy $43,549.78 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 22,222 | 20,000 | 17,778 | 15,556 | 13,333 | 11,111 | 8,889 | 6,667 | 4,444 | 2,222 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 189,533 | $53.75M | $60.59M | - | $6.84M | 12.73% | +1.628% |
ABBV AbbVie Inc. | 3,936 | $826,102.13 | $1.01M | - | $179,388.47 | 21.72% | -1.042% |
ABT Abbott Laboratories | 6,336 | $770,509.01 | $712,293.12 | - | -$58,215.89 | -7.56% | +0.744% |
ACN Accenture plc Class A | 1,872 | $455,247.59 | $354,818.86 | - | -$100,428.73 | -22.06% | +1.153% |
ACWI iShares MSCI ACWI ETF | 2,951 | $284,256.17 | $475,376.58 | - | $191,120.41 | 67.24% | -0.272% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 673 | $47,134.17 | $52,231.53 | - | $5,097.36 | 10.81% | -0.449% |
ADI Analog Devices, Inc. | 2,250 | $607,210.7 | $814,072.5 | - | $206,861.8 | 34.07% | -3.394% |
ADP Automatic Data Processing Inc. | 991 | $266,001.56 | $284,882.77 | - | $18,881.21 | 7.1% | +0.98% |
AGG iShares Core U.S. Aggregate Bond ETF | 2,713 | $270,664.59 | $264,517.5 | - | -$6,147.09 | -2.27% | -0.337% |
ALC Alcon Inc. | 3,559 | $280,497.06 | $256,354.77 | - | -$24,142.29 | -8.61% | -0.277% |
AMAT Applied Materials, Inc. | 1,963 | $718,796.44 | $906,120.82 | - | $187,324.38 | 26.06% | -4.304% |
AMD Advanced Micro Devices, Inc. | 4,626 | $997,520.06 | $2.15M | - | $1.16M | 115.92% | -2.322% |
AMGN Amgen Inc. | 4,966 | $1.75M | $2.15M | - | $394,834.2 | 22.53% | -1.05% |
AMZN Amazon.com Inc | 25,241 | $5.78M | $6.72M | - | $948,082.41 | 16.42% | +3.949% |
ANET Arista Networks, Inc. | 1,861 | $254,896.11 | $363,471.91 | - | $108,575.8 | 42.6% | -2.874% |
AOA iShares Core Aggressive Allocation ETF | 4,321 | $361,510.48 | $428,297.52 | - | $66,787.04 | 18.47% | -0.352% |
AON Aon plc | 691 | $229,246 | $245,581.39 | - | $16,335.39 | 7.13% | +1.671% |
AOR iShares Core 60/40 Balanced Allocation ETF | 272 | $16,752.82 | $19,012.8 | - | $2,259.98 | 13.49% | -0.371% |
APD Air Products and Chemicals, Inc. | 1,143 | $333,094.96 | $352,101.14 | - | $19,006.18 | 5.71% | +0.845% |
APH Amphenol Corporation | 7,830 | $538,364 | $1.23M | - | $696,583.6 | 129.39% | -2.268% |